- ICH GCP
- US Clinical Trials Registry
- Search trials
Kliniske forsøg sponsoreret af Portuguese Institute of Rheumatology
I alt 318 resultater
-
Universidade do PortoPortuguese Institute of Rheumatology; Centro de Investigação Interdisciplinar...Afsluttet
-
Universidade do PortoPortuguese Institute of Rheumatology; Centro de Investigação Interdisciplinar...RekrutteringAnkyloserende spondylitis | SpondyloarthritisPortugal
-
Institute of Rheumatology, PragueKarolinska InstitutetAfsluttetDermatomyositis | PolymyositisTjekkiet
-
University of CoimbraPortuguese Oncology Institute, CoimbraAfsluttetKræft | Biomarkører | Komplementære terapier | Ambulant pleje | Velvære, psykologiskPortugal
-
Grupo de Investigação em Bioquímica e Biologia...University of Lisbon; Dentaid SL; Portuguese Institute of RheumatologyAfsluttetLivskvalitet | Sjøgrens syndrom | Xerostomi | Hyposalivation
-
Jolanda LuimeUniversity of Oxford - Nuffield Department of Orthopaedics, Rheumatology... og andre samarbejdspartnereIkke rekrutterer endnuPsoriasisgigt | Opblussen, symptom | Psoriasisgigt forværret
-
Chinese Society of HematologyHarbin Institute of Hematology & OncologyUkendtMyelodysplastisk syndrom--CDA-2 hæmatologisk forbedring national bekræftelsesundersøgelse (MD-CHINA)Myelodysplastisk syndrom (MDS)
-
Karolinska InstitutetKing's College Hospital NHS Trust; Institute of Rheumatology, PragueAfsluttetDermatomyositis | PolymyositisSverige, Tjekkiet
-
National Institute of Geriatrics, Rheumatology...Ikke rekrutterer endnuKirurgisk procedure, uspecificeret | Fraktur af lårben | Gigt i hoften | Dysplasi; Hofte | Aseptisk nekrose
-
National Institute of Geriatrics, Rheumatology...AfsluttetKomplekse regionale smertesyndromerPolen
-
V.A. Nasonova Research Institute of Rheumatology...AstraZenecaIkke rekrutterer endnuForhøjet niveau af IFN Type I hos SLE-patienter
-
AbbottAlmedis; Scientific Research Institute of Rheumatology, MoscowAfsluttetRheumatoid arthritis | Psoriasisgigt | Ankyloserende spondylitisDen Russiske Føderation
-
Institute of Hematology & Blood Diseases HospitalIkke rekrutterer endnuDen profylaktiske værdi af Ruxolitinib til aGVHD hos HSCT-modtagere af AA
-
Institute of Hematology & Blood Diseases HospitalIkke rekrutterer endnuForekomsten af CMV-aktivering af perifert blod og bekræftet klinisk signifikant CMV-infektion inden for 24 uger efter transplantation
-
Institute of Hematology & Blood Diseases HospitalIkke rekrutterer endnuAt evaluere effektiviteten og sikkerheden af sekundær profylakse af CMV-reaktivering
-
Institute of Hematology & Blood Diseases HospitalRekrutteringCOVID-19 | Hæmatopoietisk stamcelletransplantationKina
-
Institute of Hematology & Blood Diseases HospitalRekruttering
-
Institute of Hematology & Blood Diseases HospitalRekrutteringAplastisk anæmi | Blodpladetransfusion RefractorinessKina
-
Institute of Hematology & Blood Diseases HospitalIkke rekrutterer endnu
-
Institute of Hematology & Blood Diseases HospitalRekrutteringPrecursorcelle lymfoblastisk leukæmi-lymfomKina
-
Institute of Hematology & Blood Diseases HospitalRekrutteringTransplantationsrelateret lidelseKina
-
Institute of Hematology & Blood Diseases HospitalRekrutteringTransplantationsrelateret lidelseKina
-
Institute of Hematology & Blood Diseases HospitalRekruttering
-
Institute of Hematology & Blood Diseases HospitalRekruttering
-
Institute of Hematology & Blood Diseases HospitalRekruttering
-
Institute of Hematology & Blood Diseases HospitalIkke rekrutterer endnu
-
Institute of Hematology & Blood Diseases HospitalRekrutteringLymfoblastisk leukæmi, akut, barndom | Refraktær leukæmi | Leukæmi, lymfoblastisk, akut, Philadelphia-positiv | Tilbagefaldende leukæmiKina
-
Institute of Hematology & Blood Diseases HospitalIkke rekrutterer endnuKronisk lymfatisk leukæmi | Lille lymfatisk lymfom | NydiagnosticeretKina
-
Institute of Hematology & Blood Diseases HospitalRekruttering
-
Institute of Hematology & Blood Diseases HospitalRekrutteringLymfom | Akut myeloid leukæmi | Leukæmi | Hæmofili A | Hæmofili B | Hæmofili | Myelomatose | Myelodysplastisk syndrom | Knoglemarvstransplantation | MDS | Aplastisk anæmi | Blødningsforstyrrelse | Myelom, multipel | Myelomer, multipel | Leukæmier, akut myeloid | Myeloid leukæmi, akut | Hæmofili As | Hæmofili Bs | BlodsygdomsinfektionKina
-
Institute of Hematology & Blood Diseases HospitalAktiv, ikke rekrutterendeTrombocytopeni | Mesenkymale stamcellerKina
-
Institute of Hematology & Blood Diseases HospitalAfsluttetPerifer arteriel sygdom
-
Institute of Hematology & Blood Diseases HospitalTrukket tilbageTilbagefaldende AML | T(8;21) | C-KIT mutationKina
-
Institute of Hematology & Blood Diseases HospitalUkendt
-
Institute of Hematology & Blood Diseases HospitalSuspenderet
-
Institute of Hematology & Blood Diseases HospitalAfsluttetAkut myeloid leukæmi, pædiatriskKina
-
Institute of Hematology & Blood Diseases HospitalUkendtPatologiske processer | Sygdomme i immunsystemet | Autoimmune sygdomme | Hæmatologiske sygdomme | Anæmi | Anæmi, hæmolytisk | Hæmolyse | Anæmi, hæmolytisk, autoimmunKina
-
Institute of Hematology & Blood Diseases HospitalRekrutteringGenterapi | Transfusionsafhængig beta-thalassæmiKina
-
Institute of Hematology & Blood Diseases HospitalRekruttering
-
Institute of Hematology & Blood Diseases HospitalRekruttering
-
Institute of Hematology & Blood Diseases HospitalIkke rekrutterer endnuEffektiviteten og sikkerheden af humaniseret CD25-antistof i aGVHD-profylakse blandt ældre patienter efter HID-HSCT
-
Institute of Hematology & Blood Diseases HospitalRekruttering
-
Institute of Hematology & Blood Diseases HospitalRekruttering
-
Institute of Hematology & Blood Diseases HospitalRekruttering
-
Institute of Hematology & Blood Diseases HospitalRekrutteringAllogen hæmatopoietisk stamcelletransplantation | Hæmatologisk sygdomKina
-
Institute of Hematology & Blood Diseases HospitalRekruttering
-
Institute of Hematology & Blood Diseases HospitalRekrutteringImmun trombocytopeni | BehandlingKina
-
Institute of Hematology & Blood Diseases HospitalIkke rekrutterer endnu
-
Institute of Hematology & Blood Diseases HospitalIkke rekrutterer endnuMinimal resterende sygdom | Knoglemarvstransplantation | Ph+ ALLEKina
-
Institute of Hematology & Blood Diseases HospitalRekruttering